Everest Medicines Statistics
Total Valuation
HKG:1952 has a market cap or net worth of HKD 21.44 billion. The enterprise value is 20.51 billion.
Market Cap | 21.44B |
Enterprise Value | 20.51B |
Important Dates
The last earnings date was Monday, August 25, 2025.
Earnings Date | Aug 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HKG:1952 has 353.54 million shares outstanding. The number of shares has increased by 0.25% in one year.
Current Share Class | 353.54M |
Shares Outstanding | 353.54M |
Shares Change (YoY) | +0.25% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 1.07% |
Owned by Institutions (%) | 11.98% |
Float | 262.25M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 22.99 |
PB Ratio | 4.98 |
P/TBV Ratio | 11.61 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -28.41 |
EV / Sales | 21.99 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -38.38 |
Financial Position
The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.19.
Current Ratio | 5.46 |
Quick Ratio | 5.36 |
Debt / Equity | 0.19 |
Debt / EBITDA | n/a |
Debt / FCF | -1.51 |
Interest Coverage | -31.72 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -15.87% |
Revenue Per Employee | 1.29M |
Profits Per Employee | -999,789 |
Employee Count | 665 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +176.31% in the last 52 weeks. The beta is 1.61, so HKG:1952's price volatility has been higher than the market average.
Beta (5Y) | 1.61 |
52-Week Price Change | +176.31% |
50-Day Moving Average | 68.49 |
200-Day Moving Average | 52.26 |
Relative Strength Index (RSI) | 38.20 |
Average Volume (20 Days) | 6,006,281 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1952 had revenue of HKD 932.82 million and -721.85 million in losses. Loss per share was -2.23.
Revenue | 932.82M |
Gross Profit | 654.41M |
Operating Income | -795.72M |
Pretax Income | -721.85M |
Net Income | -721.85M |
EBITDA | -651.63M |
EBIT | -795.72M |
Loss Per Share | -2.23 |
Balance Sheet
The company has 1.74 billion in cash and 805.37 million in debt, giving a net cash position of 932.44 million or 2.64 per share.
Cash & Cash Equivalents | 1.74B |
Total Debt | 805.37M |
Net Cash | 932.44M |
Net Cash Per Share | 2.64 |
Equity (Book Value) | 4.30B |
Book Value Per Share | 13.14 |
Working Capital | 1.75B |
Cash Flow
In the last 12 months, operating cash flow was -488.76 million and capital expenditures -45.63 million, giving a free cash flow of -534.39 million.
Operating Cash Flow | -488.76M |
Capital Expenditures | -45.63M |
Free Cash Flow | -534.39M |
FCF Per Share | -1.51 |
Margins
Gross margin is 70.15%, with operating and profit margins of -85.30% and -77.38%.
Gross Margin | 70.15% |
Operating Margin | -85.30% |
Pretax Margin | -77.38% |
Profit Margin | -77.38% |
EBITDA Margin | -69.86% |
EBIT Margin | -85.30% |
FCF Margin | n/a |
Dividends & Yields
HKG:1952 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.25% |
Shareholder Yield | n/a |
Earnings Yield | -3.37% |
FCF Yield | -2.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HKG:1952 has an Altman Z-Score of 3.97 and a Piotroski F-Score of 1.
Altman Z-Score | 3.97 |
Piotroski F-Score | 1 |